Merck KGaA Aktie - Fundamentalanalyse - Dividendenrendite KGV

Merck KGaA (ISIN: DE0006599905 , WKN: 659990) Market price date: 22.06.2018 Market price: 83,280 EUR
Description Data
Symbol MRK.DE
Market Capitalization 42.176.737.280,00 USD
Country Deutschland
Indices DaxHDAX
Sector Pharma
Raw Data Source IFRS in Millionen EUR
Stock Split 2014-06-30 - 2.0000/1.0000 |
Internet www.merckgroup.com
Last Balance Sheet Update 28.04.2018

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 22.06.2018
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
26,14 13,43 1,50% 7,30 39,31 13,93 2,36 2,59

Firmenbeschreibung

MERCK Kommanditgesellschaft auf Aktien, a science and technology company, operates in the healthcare, life science, and performance materials sectors worldwide. The company offers prescription medicines to treat infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, multiple sclerosis, colorectal cancer, as well as carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. It also provides over-the counter and food supplement products under the Neurobion, Bion3, Seven Seas, Nasivin, Femibion, Dolo-Neurobion, Vivera/Floratil, Sangobion, Vigantoletten, Apaisyl, and Kytta brands. In addition, the company offers life science products and services for use in the discovery, development, and manufacture of biotechnological drugs, as well as in research and application laboratories; and specialty chemicals and functional materials for applications consumer electronics, lighting, coatings, printing technology, paints, plastics, and cosmetics. It has strategic alliances with Pfizer Inc. and Baylor College of Medicine; an agreement with Bristol-Myers Squibb Company for the co-commercialization of Glucophage, an antidiabetic agent in China; a strategic collaboration and license agreement with Intrexon Corporation to develop and commercialize chimeric antigen receptor T-cell cancer therapies; and collaborations with F-star Delta Ltd. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.merckgroup.com